Symptomatic hypocalcemia after intravenous pamidronate.
A 65-year-old woman admitted for palliative care of metastatic renal/bladder carcinoma developed symptomatic hypocalcemia nine days following a single dose of pamidronate. This may have implications for management of patients following discharge from hospital.
McIntyre
E
E
Palliative Care Program, Edmonton General Hospital, Alberta, Canada.
Bruera
E
E
D000368:Aged; D000416:Alberta; D002295:Carcinoma, Transitional Cell / Q000150:complications*; D004164:Diphosphonates / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy* / Q000209:etiology; D006996:Hypocalcemia / Q000139:chemically induced*; D007262:Infusions, Intravenous; D000077268:Pamidronate; D001749:Urinary Bladder Neoplasms / Q000150:complications*
D004164:Diphosphonates; D000077268:Pamidronate